-

Trinity Life Sciences Announces the Expansion of Its Pricing & Market Access Offerings

Senior Partner Monica Martin De Bustamante to Head Up Function

WALTHAM, Mass.--(BUSINESS WIRE)--Trinity Life Sciences, a leader in global life sciences solutions, announced the significant expansion of its pricing and market access offerings. Leading the function, newly named Evidence, Value, Access & Pricing (EVAP), is Senior Partner Monica Martin De Bustamante. Ms. Martin De Bustamante had joined Trinity in October 2021 through the acquisition of CBPartners, a company she founded.

The expanded team is made up of both functional experts as well as a talented pool of centralized staff who work across project types. The two segments include:

  • Evidence Strategy – provides end-to-end evidence strategy and planning, execution of publication-grade studies and pull-through to scientific dissemination.
  • Value, Access and Pricing – delivers innovative and locally-nuanced global solutions for value, market access and pricing development and execution support.

“Ensuring reimbursement and patient access to treatments is a multifaceted process. The newly expanded EVAP function within Trinity is designed to help clients sift through the complexity and achieve a clear path forward,” said Monica Martin de Bustamante, Senior Partner, Evidence, Value, Access & Pricing. “Our global expertise is supported by our knowledge resource hubs in the United States, Europe, Latin America, Middle East and North Africa and Asia-Pacific regions allowing us to provide best-in-class work for our clients in evidence generation, value demonstration, health economics/outcomes research (HEOR), access and pricing.”

About Trinity Life Sciences

Trinity Life Sciences is a trusted strategic commercialization partner, providing evidence-based solutions for the life sciences. With 25 years of experience, Trinity is committed to solving clients’ most challenging problems through exceptional levels of service, powerful tools and data-driven insights. Trinity’s range of products and solutions includes industry-leading benchmarking solutions, powered by TGaS Advisors. To learn more about how Trinity is elevating life sciences and driving evidence to action, visit trinitylifesciences.com.

Contacts

Elizabeth Marshall
Trinity Life Sciences
emarshall@trinitylifesciences.com

Trinity Life Sciences


Release Summary
Trinity Life Sciences Announces the expansion of its pricing and market access offerings.
Release Versions

Contacts

Elizabeth Marshall
Trinity Life Sciences
emarshall@trinitylifesciences.com

More News From Trinity Life Sciences

Trinity Appoints Scott Evangelista as CEO to Lead Next Chapter

WALTHAM, Mass.--(BUSINESS WIRE)--Trinity, a global leader in technology-enabled commercialization solutions for the life sciences industry, today announced Scott Evangelista has been appointed Chief Executive Officer, succeeding Leslie Orne who is stepping down after three years as CEO and over 24 years with the company. Ms. Orne will transition to the role of Senior Advisor and serve as a member of Trinity’s Board of Directors. Over her distinguished tenure, Ms. Orne helped guide Trinity’s evo...

GSK, Amgen and AstraZeneca Lead the Pack in Trinity’s 2025 Digital Marketing Competency Report

WALTHAM, Mass.--(BUSINESS WIRE)--Trinity, a leader in global life sciences commercialization, today announced the release of its 5th Annual TGaS Digital Marketing Competency Report, a three-part series benchmarking the digital marketing presence of more than 150 biopharma brands. The 2025 edition reveals a significant leap forward in the industry’s digital sophistication, with a 19% increase in Proficient brands and a surge of innovation in patient engagement strategies. The report ranks each b...

Trinity Expands Global Footprint with Acquisition of EVERSANA’s APACME Advisory Services

WALTHAM, Mass.--(BUSINESS WIRE)--Trinity, a leader in global life sciences commercialization solutions and recognized for being a strategic, tech-enabled commercialization company that empowers pharma, biotech, and medtech organizations to advance medical innovations, announced today the acquisition of EVERSANA’s advisory services operation in Asia-Pacific and the Middle East (APACME). The strategic acquisition will transition EVERSANA’s advisory services operation in APACME to Trinity, further...
Back to Newsroom